Myers Michael
Insider CIK 1959547 · QNRX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QNRX Quoin Pharmaceuticals, Ltd | P Buy deriv | 2026-08-31 | 2026-09-01 | 10,245 | — | $0 | 10,245 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy | 2026-08-31 | 2026-09-01 | 20,490 | $4.88 | $100.0K | 37,713 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy deriv | 2026-08-31 | 2026-09-01 | 10,245 | — | — | 10,245 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy | 2026-08-31 | 2026-09-01 | 20,490 | $4.88 | $100.0K | 37,713 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2026-02-04 | 2026-02-06 | 318,750 | — | $0 | 318,750 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2025-05-29 | 2025-06-02 | 42,039 | — | $0 | 42,039 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2025-05-29 | 2025-06-13 | 42,857 | — | $0 | 42,857 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy deriv | 2024-12-23 | 2024-12-27 | 555,556 | — | $0 | 555,556 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy deriv | 2024-12-23 | 2024-12-27 | 555,556 | — | $0 | 555,556 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy | 2024-12-23 | 2024-12-27 | 555,556 | $0.45 | $250.0K | 602,808 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2024-12-09 | 2024-12-10 | 536,603 | — | $0 | 536,603 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy | 2024-09-04 | 2024-09-05 | 8,200 | $0.75 | $6.2K | 23,680 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy | 2024-09-04 | 2024-09-05 | 23,572 | $0.80 | $18.9K | 47,252 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy | 2024-09-04 | 2024-09-05 | 5,322 | $0.66 | $3.5K | 15,480 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy | 2024-09-03 | 2024-09-05 | 800 | $0.62 | $496 | 10,158 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2023-10-26 | 2023-10-30 | 80,965 | — | $0 | 80,965 | SEC↗ |